Inside Drug Pricing - 10/14/2019

Grogan: White House Backs Inflation Rebates In Senate Drug Pricing Bill

By John Wilkerson / October 8, 2019 at 6:59 PM
The White House is bucking the GOP by supporting a measure in the Senate Finance drug pricing bill that would make drug companies pay back the government when they raise prices faster than inflation, White House Domestic Policy Council head Joe Grogan said Tuesday (Oct. 8) at an event in Washington sponsored by the investment bank UBS. The UBS event was closed to press, but attendees relayed Grogan’s remarks. Many Republicans oppose the inflation rebates, and the measure fell one...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.